- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Biocon Limited — Updates, 15-01-2026: Press Release
15-01-2026 | 09:16 am
15-01-2026 | 09:16 am
Biocon completed a Rs 4,150 Cr equity fundraise to fully acquire Viatris's stake in Biocon Biologics. This makes Biocon Biologics a wholly-owned subsidiary, strengthening Biocon's leadership in biosimilars for diabetes, oncology, and immunology.
No comments yet. Be the first to comment!